Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Fea

Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar on April 16th, 2024 - Algernon Pharmaceuticals (OTC:AGNPF)

VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") (CSE:AGN) (FRANKFURT: AGW0) (OTCQB:AGNPF), is pleased to invite investors and other interested

Related Keywords

United Kingdom , Canada , Vancouver , British Columbia , Canadian , British , Martin Gagel , Christopherj Moreau , Algernon Pharmaceuticals , Company Or Algernon , Neither The Canadian Securities Exchange , Radius Research Pitch , Market Radius Capital Inc , Market Radius Research , Canadian Securities Exchange , Algernon Pharmaceuticals Inc , Seyltx Inc , Market Radius , Deep Dive , Registration Link , Radius Research , Market Radius Capital , Algernon Neuroscience , Market Regulator ,